Affiliation:
1. V. A. Nasonova Research Institute of Rheumatology
Abstract
In rheumatology in recent years, the importance of comorbid infections has increased significantly, especially in connection with the introduction of genetic engineering biological drugs into clinical practice. One way to solve this problem is to study and actively use various vaccines. This review provides an updated version of the recommendations for vaccinating adult patients with autoimmune inflammatory rheumatic diseases, proposed in 2019 by experts from the European Anti-Rheumatic League (EULAR). Issues regarding the use of influenza vaccines, infections caused by Pneumococci, Hepatitis B viruses, herpes and human papillomaviruses in rheumatological patients are considered. The main directions of future research on this issue are outlined.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference53 articles.
1. Wolfe F., Mitchell D. M., Sibley J. T. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994; 37 (4): 481–494.
2. Edwards C. J., Lian T. Y., Badsha H., et al. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus. 2003; 12 (9): 672–676.
3. Tyndall A.J, Bannert B., Vonk M., et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69 (10): 1809–15. DOI: 10.1136/ard.2009.114264.
4. Reshetnyak T. M. Antifosfolipidnyi sindrom: klinika, diagnostika i voprosy patogeneza. Avtoref. diss… dokt. med. nauk. M.,1999. 57 s.
5. Asherson R.A, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome — molecular mimicry? J Rheumatol. 2000; 27 (1): 12–14.